Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of “Moderate Buy” by Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has received an average recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $77.50.

A number of research analysts have issued reports on HSIC shares. StockNews.com cut shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th.

Henry Schein Stock Up 0.2 %

Henry Schein stock opened at $70.37 on Monday. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The business has a fifty day moving average price of $70.63 and a 200-day moving average price of $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The stock has a market capitalization of $8.92 billion, a price-to-earnings ratio of 26.06, a PEG ratio of 2.02 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The business had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. During the same quarter last year, the company earned $1.31 earnings per share. The company’s quarterly revenue was up .0% on a year-over-year basis. Equities research analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Insider Activity

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Cromwell Holdings LLC grew its stake in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares in the last quarter. Summit Securities Group LLC purchased a new stake in Henry Schein in the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA acquired a new stake in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. boosted its stake in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.